Management and outcome in foreign-born vs native-born patients with myocardial infarction in Sweden

Author:

Zwackman Sammy1ORCID,Häggström Jenny2,Hagström Emil34ORCID,Jernberg Tomas5,Karlsson Jan-Erik67,Lawesson Sofia Sederholm1ORCID,Leosdottir Margret89ORCID,Ravn-Fischer Annica1011ORCID,Eriksson Marie2,Alfredsson Joakim1ORCID

Affiliation:

1. Department of Health, Medicine and Caring Sciences, Division of Diagnostics and Specialist Medicine, Unit of Cardiovascular Sciences, Linköping University , Linköping 581 83 , Sweden

2. Department of Statistics, Umeå School of Business, Economics and Statistics, Umeå University , Umeå 901 87 , Sweden

3. Department of Medical Sciences, Cardiology, Uppsala University , Uppsala 751 85 , Sweden

4. Uppsala Clinical Research Centre, Uppsala University , Dag Hammarskölds Väg 38, Uppsala 751 85 , Sweden

5. Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute , Stockholm 171 77 , Sweden

6. Department of Medical and Health Sciences, Linköping University , Linköping 581 83 , Sweden

7. Department of Internal Medicine, County Hospital Ryhov , Jönköping 551 85 , Sweden

8. Department of Cardiology, Skane University Hospital , Carl-Bertil Laurells gata 9, 214 28, Malmö , Sweden

9. Department of Clinical Sciences, Lund University , Sölvegatan 19 – BMC 112, 221 84 Lund, Malmö , Sweden

10. Institution of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Gothenburg University , Box 100, 405 30 Gothenburg , Sweden

11. Department of Cardiology, Sahlgrenska University Hospital , 413 45 Gothenburg , Sweden

Abstract

Abstract Aims Previous studies on disparities in healthcare and outcomes have shown conflicting results. The aim of this study was to assess differences in baseline characteristics, management, and outcomes in myocardial infarction (MI) patients, by country of birth. Methods and results In total, 194 259 MI patients (64% male, 15% foreign-born) from the nationwide SWEDEHEART (The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies) registry were included and compared by geographic region of birth. The primary outcome was 1-year major adverse cardiovascular events (MACEs) including all-cause death, MI, and stroke. Secondary outcomes were long-term MACE (up to 12 years), the individual components of MACE, 30-day mortality, management, and risk factors. Logistic regression, Cox proportional hazard models, and propensity score match (PSM), accounting for baseline differences, were used. Foreign-born patients were younger, often male, and had a higher cardiovascular (CV) risk factor burden, including smoking, diabetes, and hypertension. In PSM analyses, Asia-born patients had higher likelihood of revascularization [odds ratio 1.16, 95% confidence interval (CI) 1.04–1.30], statins and beta-blocker prescription at discharge, and a 34% lower risk of 30-day mortality. Furthermore, no statistically significant differences were found in primary outcomes except for Asia-born patients having lower risk of 1-year MACE [hazard ratio (HR) 0.85, 95% CI 0.73–0.98], driven by lower mortality (HR 0.72, 95% CI 0.57–0.91). The results persisted over the long-term follow-up. Conclusion This study shows that in a system with universal healthcare coverage in which acute and secondary preventive treatments do not differ by country of birth, foreign-born patients, despite higher CV risk factor burden, will do at least as well as native-born patients.

Funder

Kamprad Family Foundation

Publisher

Oxford University Press (OUP)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3